Tropisetron versus metoclopramide in the control of emesis in far- advanced cancer

Oncologist

Volumn 2, Issue 5, 1997, Pages 319-323

  Mystakidou, K ^a   Befon, S ^a   Trifyllis, J ^a   Liossi, C ^a   Papadimitriou, J ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Emesis; Far advanced cancer; Metoclopramide; Nausea; Tropisetron; Vomiting

Indexed keywords

DEXAMETHASONE; METOCLOPRAMIDE; TROPISETRON;

ADULT; AGED; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; FEMALE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PANCREAS CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING; VOMITING;

EID: 0030726201     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2-5-319     Document Type: Article

References (9)

1. Twycross R. Symptom Management in Advanced Cancer. Oxford and New York: Radcliffe Medical Press, 1995;168.
2. Reuben DB, Mar V. Nausea and vomiting in terminal cancer patients. Arch Intern Med 1983;146:2021-2023.
3. Allan SG. Nausea and vomiting. In: Doyle D, Hanks GW, MacDonald N, eds. Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1996;282-290.
4. Bruere E, Seifert L. Chronic nausea in advanced cancer patients: a retrospective assessment of a MET-based antiemetic regimen. J Pain Symptom Manage 1996;11:147-153
5. Kris MG, Leslie B, Tyson LB et al. Extrapyramidal reactions with high-dose metoclopramide. New Engl J Med (Letter) 1983;7:433.
6. McVie JG, de Bruijn KM. Methodology of antiemetic trials. Drugs 1992;43(suppl 3):1-5.
7. Lee CR, Plosker GL, McTavish D. Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic. Drugs 1993;46:925-943.
8. 3 receptor antagonists injected into the area postrema inhibit cis-platin induced emesis in the ferret. Br J Pharmacol 1989;97:247-255
9. Richardson BP, Engel G, Donatsh P et al. Identification of serotonin-M receptor sub-types and their specific blockade by a new class of drugs. Nature 1985;316:126-131.